Израел -
иврит -
Ministry of Health
בנליסטה תוך ורידי 120 מג
glaxo smith kline (israel) ltd - belimumab - אבקה להכנת תמיסה מרוכזת לעירוי - belimumab 120 mg - belimumab - belimumab - benlysta is indicated as add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (sle) with a high degree of disease activity (e.g positive anti dsdna and low complement) despite standard therapy.
Израел -
иврит -
Ministry of Health
בנליסטה תוך ורידי 400 מג
glaxo smith kline (israel) ltd - belimumab - אבקה להכנת תמיסה מרוכזת לעירוי - belimumab 400 mg - belimumab - belimumab - benlysta is indicated as add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (sle) with a high degree of disease activity (e.g positive anti dsdna and low complement) despite standard therapy.
Израел -
иврит -
Ministry of Health
טקרוסל 0.5 מג
padagis israel agencies ltd, israel - tacrolimus as monohydrate - קפסולות - tacrolimus as monohydrate 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.
Израел -
иврит -
Ministry of Health
טקרוסל 1 מג
padagis israel agencies ltd, israel - tacrolimus as monohydrate - קפסולות - tacrolimus as monohydrate 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.
Израел -
иврит -
Ministry of Health
טקרוסל 5 מג
padagis israel agencies ltd, israel - tacrolimus as monohydrate - קפסולות - tacrolimus as monohydrate 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.